首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1741249

雌激素阻斷劑市場：依產品類型、應用、通路和地區分類

Estrogen Blockers Market, By Product Type, By Application, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

雌激素阻斷劑市場規模預計在 2025 年達到 170.4 億美元，預計到 2032 年將達到 264.8 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 6.5%。

分析範圍		分析詳細資訊
基準年	2024	市場規模（2025年）	170.4億美元
效能數據	2020-2024	預測期	2025-2032
預測期內的年複合成長率（2025-2032）	6.50%	預計金額（2032年）	264.8億美元

雌激素阻斷劑是FTM（女變男）患者在荷爾蒙補充療法（HRT）中用來抑制體內雌激素作用的藥物。它們也能促進男性第二性徵的發展。雌激素阻斷劑種類繁多，有些效果較佳。

雌激素阻斷劑可以錠劑或注射劑形式服用。它們通常作為更大規模HRT治療方案的一部分開具，患者通常耐受性良好。在大多數情況下，服用這些藥物不需要住院，通常可以在家中服用。

市場動態

雌激素阻斷劑主要用於治療荷爾蒙相關疾病，如卵巢症候群（PCOS）、子宮內膜異位症、乳癌等。隨著這些疾病在國際上的盛行率增加，對雌激素阻斷劑的需求也在上升，刺激了市場擴張。

例如，根據世界衛生組織（WHO）2023年6月28日發布的報告，卵巢症候群（PCOS）是一個重大的公共衛生問題，被認為是影響育齡婦女最常見的荷爾蒙失調之一。據估計，該疾病每年影響8-13%的育齡婦女，高達70%的病例未被診斷出來。

然而，與任何藥物一樣，雌激素阻斷劑也存在潛在的風險和副作用。潮熱、憂鬱、關節不適和膽固醇升高是一些典型的副作用。在某些情況下，長期使用雌激素阻斷劑可能會增加心血管疾病和骨質疏鬆的風險。安全性問題和潛在的副作用可能會影響患者對雌激素阻斷劑的依從性和接受度。

本報告的主要特點

本報告對全球雌激素阻斷劑市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和年複合成長率。
它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球雌激素阻斷劑市場的主要企業是根據以下參數列出的，例如公司概況、產品系列、主要亮點、財務表現和策略。
透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
「全球雌激素阻斷劑市場」報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球雌激素阻斷劑市場的各種策略矩陣來更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 17.04 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 26.48 Bn

Estrogen blockers are medicines that are used by FTM (female to male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of estrogen blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

For instance, on June 28, 2023, according to a report published by the World Health Organization, reported that polycystic ovary syndrome (PCOS) is a significant public health problem and considered as one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age every year, and up to 70% of cases are undiagnosed.

On the other hand, like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term use of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:

This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global estrogen blockers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Olema Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Allorion Therapeutics Inc, Carrick Therapeutics Limited, Criterium, Inc. and Hoffmann-La Roche
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market

Detailed Segmentation:

Global Estrogen Blockers Market, By Product Type:
- Selective Estrogen Receptor Modulators (SERMs)
- Aromatase Inhibitors
- Estrogen Receptor Downregulators (ERDs)
- Others
Global Estrogen Blockers Market, By Application:
- Breast Cancer Treatment
- Hormone Replacement Therapy (HRT)
- Infertility Treatment
- Post-Menopausal Osteoporosis
- Others
Global Estrogen Blockers Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Estrogen Blockers Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Pfizer Inc.
- Novartis AG
- AstraZeneca PLC
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol Myers Squibb Company
- Sanofi S.A.
- AbbVie Inc.
- GlaxoSmithKline plc
- Olema Pharmaceuticals, Inc.
- Scorpion Therapeutics, Inc.
- Allorion Therapeutics Inc
- Carrick Therapeutics Limited
- Criterium, Inc.
- F.Hoffmann-La Roche

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Estrogen Blockers, By Product Type
- Market Estrogen Blockers, By Application
- Market Estrogen Blockers, By Distribution Channel
- Market Estrogen Blockers, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Hormone-related Disorders
- Restraints
Side Effects and Safety Concerns
- Opportunities
Expansion of Indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Estrogen Blockers Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Selective Estrogen Receptor Modulators (SERMs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Aromatase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Estrogen Receptor Downregulators (ERDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Estrogen Blockers Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Breast Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hormone Replacement Therapy (HRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Infertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Post-Menopausal Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Estrogen Blockers Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Estrogen Blockers Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bristol Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Olema Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Scorpion Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Allorion Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Carrick Therapeutics Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Criterium, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

Raloxifene雷洛昔芬市場：按劑型、分銷管道分類 - 全球預測 2025-2030

FAQ

雌激素阻斷劑市場：依產品類型、應用、通路和地區分類

Estrogen Blockers Market, By Product Type, By Application, By Distribution Channel, By Geography

市場動態

本報告的主要特點

目錄

第1章調查目的與前提條件

第2章市場展望

第3章市場動態、法規與趨勢分析

4. 全球雌激素阻斷劑市場：COVID-19感染疾病的影響

5. 全球雌激素阻斷劑市場（依產品類型）（2020-2032）

6. 全球雌激素阻斷劑市場應用（2020-2032）

7. 全球雌激素阻斷劑市場依通路分類（2020-2032）

8. 全球雌激素阻斷劑市場（按地區）（2020-2032）

第9章競爭態勢

第 10 章章節

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Estrogen Blockers Market, By Product Type, 2020-2032, (US$ Bn)

6. Global Estrogen Blockers Market, By Application, 2020-2032, (US$ Bn)

7. Global Estrogen Blockers Market, By Distribution Channel, 2020-2032, (US$ Bn)

8. Global Estrogen Blockers Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

雌激素阻斷劑市場：依產品類型、應用、通路和地區分類

Estrogen Blockers Market, By Product Type, By Application, By Distribution Channel, By Geography

市場動態

本報告的主要特點

目錄

第1章 調查目的與前提條件

第2章 市場展望

第3章市場動態、法規與趨勢分析

4. 全球雌激素阻斷劑市場：COVID-19感染疾病的影響

5. 全球雌激素阻斷劑市場（依產品類型）（2020-2032）

6. 全球雌激素阻斷劑市場應用（2020-2032）

7. 全球雌激素阻斷劑市場依通路分類（2020-2032）

8. 全球雌激素阻斷劑市場（按地區） （2020-2032）

第9章 競爭態勢

第 10 章 章節

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Estrogen Blockers Market, By Product Type, 2020-2032, (US$ Bn)

6. Global Estrogen Blockers Market, By Application, 2020-2032, (US$ Bn)

7. Global Estrogen Blockers Market, By Distribution Channel, 2020-2032, (US$ Bn)

8. Global Estrogen Blockers Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

第1章調查目的與前提條件

第2章市場展望

8. 全球雌激素阻斷劑市場（按地區）（2020-2032）

第9章競爭態勢

第 10 章章節